Insider · CIK 0001500189
Julia Marie Eastland
Files at LNTH (Lantheus Holdings, Inc.), ZNTL (Zentalis Pharmaceuticals, Inc.). First filing Feb 4, 2025, latest Feb 10, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZNTL: Zentalis Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Zentalis Pharmaceuticals, Inc. | $21k 8,755 shares | -10% | +130% from low-36% from high | |
| 48Moderate | Zentalis Pharmaceuticals, Inc. | $49k 28,500 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,866 | $2.43 | $19k | 80,022 | Feb 10, 2026 |
| Feb 9, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -889 | $2.39 | $2,127 | 79,133 | Feb 10, 2026 |
| Jan 8, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +775,000 | $0.00 | $0 | 775,000 | Jan 9, 2026 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Common Stock | +2,537 | $0.00 | $0 | 3,882 | May 16, 2025 |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,543 | $0.00 | $0 | 4,543 | May 16, 2025 |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +59,388 | $0.00 | $0 | 87,888 | Feb 5, 2025 |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +59,388 | $0.00 | $0 | 59,388 | Feb 5, 2025 |
| Jan 31, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +28,500 | $1.73 | $49k | 28,500 | Feb 4, 2025 |
| Dec 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,028,800 | $0.00 | $0 | 3,028,800 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.